Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Press release: Sequana Medical Secures Additional Convertible Financing of EUR…
Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders Continued strong support from major shareholders alfapump® US commercial launch remains on track for Q3 2025 through specialty commercial team focused on liver transplant centersCash runway extended into Q1 2026 based on expected drawdowns of the initial EUR 20 million commitment under the GEM committed share subscription facility Ghent, Belgium, 27...
Nasdaq GlobeNewswire
27/05/2025
Press Release: Sanofi completes acquisition of DR-0201
Sanofi completes acquisition of DR-0201Paris, May 27, 2025.Sanofi announces the completion of itsacquisition of DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private clinical-stage biopharmaceutical company. The acquisition bolsters Sanofi's ambition to become the foremost immunology company and broadens the company's leading immunology pipeline.DR-0201, now named SAR448501, has shown robust B-cell depletion in pre-clinical and early clinical studies...
Nasdaq GlobeNewswire
27/05/2025
Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik
Introduced to a global audience through exclusive live demonstrations, Alma IQ, redefines how practitioners and patients approach aesthetic care from the very first consultation. By delivering real-time, high-definition insights beneath the skin's surface, the platform reveals what the eye cannot see, empowering aesthetic professionals to make informed decisions with unprecedented precision. Introduced to a global audience through exclusive live demonstrations, Alma IQ, redefines how...
PR Newswire
27/05/2025
Vivoryon Therapeutics N.V. Expands Intellectual Property Portfolio with New U.S…
Vivoryon Therapeutics N.V. Expands Intellectual Property Portfolio with New U.S. Composition of Matter Patent Granted for Varoglutamstat Newly granted U.S. patent expected to provide exclusivity through 2044 with subsequent opportunity for patent term extensionNew U.S. patent granted after accelerated examination process covers the active polymorph of varoglutamstat, Vivoryon's lead drug in development Additional patents for medical use and dosing regimens under examination for...
Nasdaq GlobeNewswire
27/05/2025
Rett Syndrome Market Sees Momentum with Novel Gene and Protein-Targeted…
It is the second leading cause of severe intellectual disability in females. During the stage of developmental regression, many individuals with Rett syndrome also meet the diagnostic criteria for autism spectrum disorder (ASD). The condition mostly affects females because it is linked to mutations on the X chromosome. Females have two X chromosomes, which can provide some genetic compensation, whereas males, who have only one X chromosome, are less likely to survive if the MECP2 gene is…
PR Newswire
26/05/2025
Alvotech Annual General Meeting to be held June 25, 2025
The Annual General Meeting of Alvotech will be held on Wednesday June 25, 2025, at 09.00 a.m. CEST at the premises of Arendt & Medernach at 41A, Avenue John F. Kennedy L-1855 Luxembourg, Grand Duchy of Luxembourg. Reference is made to the attached document with regard to the final agenda.Meeting materials and all further information about the Annual General Meeting is available on the Alvotech website:https://investors.alvotech.com/corporate-governance/annual-general-meeting-2025...
Nasdaq GlobeNewswire
26/05/2025
Microbiome Cosmetic Market to Hit USD 2.24 Billion by 2031 | Driven by Skin…
Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-38O7122/Global_Microbiome_Cosmetic_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-38O7122/Global_Microbiome_Cosmetic_Market Major Factors Driving the Growth of Microbiome Cosmetic Market: The Microbiome Cosmetic Market is expanding rapidly as consumers and brands alike recognize the importance of maintaining healthy skin microbiota. It spans across skincare, hair...
PR Newswire
26/05/2025
Iba – Acquisition of Own Shares
Immediate Release – May 26 th, 2025 Louvain-la-Neuve, Belgium, May 26 th, 2025 -In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24 th, 2025. Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of...
Nasdaq GlobeNewswire
26/05/2025
Valneva to Participate at U.S. and European Investor Conferences in June
Saint-Herblain (France), May 26, 2025–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and hold investor meetings at several upcoming investor conferences in the United States and Europe in June 2025. Key topics for discussion include Valneva's commercial stage vaccines and its differentiated portfolio of vaccine candidates, including VLA15, the world's leading Lyme disease vaccine candidate. VLA15 is...
Nasdaq GlobeNewswire
26/05/2025
Plant-based Supplements Market worth $42.27 billion by 2030- Exclusive Report by…
Browse in-depth TOC on "Plant-based Supplements Market" Browse in-depth TOC on "Plant-based Supplements Market" 336 – Tables 71 – Figures 350 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239782374 Protein supplements are estimated to account for a significant share of the market by product type Protein supplements are maintaining a significant market share in the plant-based supplement segment, fueled by a growing interest in...
PR Newswire
26/05/2025
Negative Pressure Wound Therapy Market worth US$3.84 billion by 2030 with 6.9%…
Browse in-depth TOC on "Negative Pressure Wound Therapy Market" Browse in-depth TOC on "Negative Pressure Wound Therapy Market" 233 - Tables46 - Figures248 - Pages By Based on wound type,the negative pressure wound therapy market is divided into five main segments based on wound type: burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. The burns and surgical & open wounds segment held the largest...
PR Newswire
26/05/2025
Healthcare Contract Manufacturing Market Size worth $347.5 Billion, Globally, by…
Market Overview and Growth Trajectory: Market Overview and Growth Trajectory: Healthcare Contract Manufacturing Market Growth: According to an exhaustive report by The Research Insights, the Healthcare Contract Manufacturing Market is experiencing significant growth. The development of several key trends that are influencing the industry landscape. Healthcare companies are driving market growth through their need for affordable manufacturing services. The need to lower operational...
PR Newswire
26/05/2025
Transactions in Connection with Share Buy-back Program
Company Announcement COPENHAGEN, Denmark; May 26, 2025 – Genmab A/S (Nasdaq: GMAB).On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program. The share buy-back program is expected to be completed no later than July 10, 2025.The following transactions were executed under the program from May 19 to May 23, 2025: Trading PlatformNo...
Nasdaq GlobeNewswire
26/05/2025
Transactions under Novonesis' share buyback program
Please read the announcement in PDF Attachment 2025_26_Share_buyback_program
Nasdaq GlobeNewswire
26/05/2025
Happiest Health Launches Happiest Physio Clinic in Koramangala, Bengaluru
This initiative is part of Happiest Health's long-term vision to create health-first ecosystems that are rooted in prevention, education, and community engagement. This initiative is part of Happiest Health's long-term vision to create health-first ecosystems that are rooted in prevention, education, and community engagement. Arvind Krishnan, President & CEO – Wellness, Happiest Health said, "With Happiest Physio, we are addressing a growing yet underserved need. From everyday desk...
PR Newswire
26/05/2025
Esaote: The new MyLab™Heron ultrasound scanner for veterinary physicians had its…
"Veterinary physicians," stated Erminio Bassi, Esaote Vet Business Manager, "are always looking for tools that improve accuracy and efficiency, and this new ultrasound system meets these needs perfectly." "Veterinary physicians," stated Erminio Bassi, Esaote Vet Business Manager, "are always looking for tools that improve accuracy and efficiency, and this new ultrasound system meets these needs perfectly." MyLab™Heronis inspired by the animal from which it…
PR Newswire
26/05/2025
GUINEA-BISSAU LOOKS TO THE FUTURE OF PUBLIC HEALTH: HEALTH MINISTER PEDRO TIPOTE…
The visit also served as a platform to discuss expanding the collaboration to include the creation of a national pharmaceutical manufacturing facility, initially focused on essential medicines, a strategic move not only for Guinea-Bissau but for neighboring countries within the Economic Community of West African States (ECOWAS). Enhancing pharmaceutical logistics was also discussed, with digital solutions for the central warehouse and regional distribution to ensure nationwide continuity and…
PR Newswire
26/05/2025
Guerbet : Changes in the composition of the Guerbet board of directors.
CHANGES IN THE COMPOSITION OF THEGUERBET BOARD OF DIRECTORS Reorganization of the Board of DirectorsDirectors' terms of office reduced to 4 yearsAppointment of Ms Michèle Lesieur and Mr Eric Drapé as independent directorsReappointment of two directors _________________________________________________________________Villepinte, May 23rd, 2025 Guerbet(FR0000032526 GBT), a global specialist in contrast media and solutions for medical imaging, announces,...
Nasdaq GlobeNewswire
26/05/2025
Casino Group and H&S Invest Holding plan to open 210 convenience stores in…
Casino Group and H&S Invest Holding plan to open210 convenience stores in Morocco with by 2035Casino Group and H&S Invest Holding sign a strategic partnership agreement to deploy the French Group's brands in Morocco. The aim of this exclusive partnership is to open more than 210 Franprix and Monoprix brand stores over the next ten years throughout Morocco. The partnership marks a decisive step inCasino Group 's new international expansion strategy, which is leveraging...
Nasdaq GlobeNewswire
26/05/2025
GIG GULF SECURES CATEGORY "A" HEALTH INSURANCE LICENSE UNDER NEW REGULATORY…
Mehdi Al Harthy, General Manager of GIG Gulf Oman, said, "We are committed to leveraging our expertise and technology to deliver tailored insurance solutions that meet the unique needs of individuals and businesses across Oman. Our focus is on building long-term partnerships and enhancing customer experience through transparency, accessibility, and trust." Mehdi Al Harthy, General Manager of GIG Gulf Oman, said, "We are committed to leveraging our expertise and technology to…
PR Newswire
26/05/2025
Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at…
The increasing utilisation of point-of-care ultrasound in the ICU has transformed patient assessment and management. The new BeneVision V Series connects with ultrasound systems, including the TE Air handheld ultrasound, to systemically integrate imaging data for more insightful decision-making support. This bedside innovation enables clinicians to get clearer ultrasound images on screen, so they can visualise, analyse and document ultrasound findings both in real-time and through historical…
PR Newswire
26/05/2025
Industry Forums at 137th Canton Fair Spotlight Emerging Trends and Global…
On April 23, another pivotal forum addressed brand globalization in the home and construction materials sector. Experts and company leaders shared approaches for strengthening reach in the international market. Professor Dai Yonghong of Shenzhen University emphasized the importance of combining AI with a deep understanding of Chinese market strengths to navigate global trade uncertainties. Shi Zhicheng from the China Quality Certification Center highlighted the need to embed carbon reduction…
PR Newswire
26/05/2025
ZLNA – Issuance of shares through set-off of option exercise fee
After the share capital increase related to the issuance of the new shares has been registered with the Norwegian Register of Business Enterprises, the Company will have a share capital of NOK 20,454,162, divided into 20,454,162 shares, each with a par value of NOK 1.For further information, please contact: Hans Vassgård Eid, CFO, Zelluna ASAEmail:
[email protected]
: +47 482 48632About Zelluna ASAZelluna's mission is to deliver transformative treatments with the...
Nasdaq GlobeNewswire
24/05/2025
Information on the total number of voting rights and shares
Information on the total number of voting rights and sharesMont-Saint-Guibert (Belgium), May 23, 2025, 10:30 pm CET / 4:30 pm ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 6,430,026.16 Total number of securities carrying voting rights: 37,429,265 (all ordinary shares) Total number of voting...
Nasdaq GlobeNewswire
23/05/2025
Altri Comunicati